Sygnia CEO David Hufton said, “The healthcare sector has never been more relevant than it is right now. By listing this ETF on A2X, our local investors not only have exposure to international companies at the forefront of scientific innovation and healthcare, they are also able to extract additional benefits and save money through A2X’s low-cost platform when they transact.”